Nisa Investment Advisors LLC Acquires 27,857 Shares of Cencora, Inc. $COR

01 Apr 2026, 10:36 by Tristan Rich · The Markets Daily

Nisa Investment Advisors LLC raised its holdings in shares of Cencora, Inc. (NYSE:COR – Free Report) by 36.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 104,962 shares of the company’s stock after acquiring an additional 27,857 shares during the quarter. Nisa Investment Advisors LLC owned approximately 0.05% of Cencora worth $35,451,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Marshall Wace LLP raised its holdings in Cencora by 518.9% in the 3rd quarter. Marshall Wace LLP now owns 1,995,118 shares of the company’s stock worth $623,534,000 after purchasing an additional 1,672,762 shares during the period. Mizuho Markets Americas LLC grew its holdings in Cencora by 116.4% during the third quarter. Mizuho Markets Americas LLC now owns 212,800 shares of the company’s stock valued at $66,506,000 after purchasing an additional 1,511,906 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Cencora by 528.9% during the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,475,859 shares of the company’s stock valued at $461,250,000 after purchasing an additional 1,241,186 shares during the period. Viking Global Investors LP increased its position in Cencora by 95.0% in the second quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock worth $624,207,000 after buying an additional 1,013,913 shares in the last quarter. Finally, Vanguard Group Inc. increased its position in Cencora by 4.1% in the third quarter. Vanguard Group Inc. now owns 23,395,547 shares of the company’s stock worth $7,311,810,000 after buying an additional 916,506 shares in the last quarter. Institutional investors own 97.52% of the company’s stock.

Insider Transactions at Cencora

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of Cencora stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total value of $1,807,704.08. Following the sale, the chief executive officer directly owned 66,726 shares in the company, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.38% of the company’s stock.

Cencora Stock Up 1.3%

NYSE COR opened at $313.88 on Wednesday. The stock’s 50 day moving average is $350.42 and its 200 day moving average is $341.25. The company has a current ratio of 0.92, a quick ratio of 0.51 and a debt-to-equity ratio of 3.62. Cencora, Inc. has a 12 month low of $267.40 and a 12 month high of $377.54. The stock has a market cap of $61.06 billion, a PE ratio of 37.73, a P/E/G ratio of 1.44 and a beta of 0.68.

Cencora (NYSE:COR – Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. The business had revenue of $85.93 billion during the quarter, compared to analyst estimates of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The company’s revenue was up 5.5% on a year-over-year basis. During the same period last year, the firm posted $3.73 EPS. Research analysts predict that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is presently 28.85%.

Analyst Upgrades and Downgrades

COR has been the topic of a number of analyst reports. Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a research report on Tuesday, March 17th. Bank of America reduced their target price on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a report on Monday, January 5th. Wells Fargo & Company raised their target price on shares of Cencora from $405.00 to $429.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Evercore reaffirmed an “outperform” rating on shares of Cencora in a report on Tuesday, March 17th. Finally, Robert W. Baird set a $415.00 price target on shares of Cencora in a research report on Tuesday, January 13th. Twelve equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $403.17.

Get Our Latest Analysis on Cencora

About Cencora

(Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.